TE_18

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family AluJr
TE superfamily Alu
TE class SINE
Gene C1orf159
Class Chimeric
Coding Non-coding, Other
Tumor-specific score 0.79
Counts of samples TCGA_tumor:66; TCGA_normal:0; GTEx:94
TSS chr1(-):1103768



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_18.11 C1orf159 Chimeric Non-coding Non-coding chr1(-):1090408,1090428,1091278,1091374,1091472,1091565,1091991,1092103,1103723,1103769
teRNA_18.12 C1orf159 Chimeric Non-coding Non-coding chr1(-):1087577,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1092566,1095124,1103723,1103769
teRNA_18.13 C1orf159 Chimeric Non-coding Non-coding chr1(-):1090408,1090428,1091278,1091374,1091472,1091565,1091991,1092103,1092566,1095124,1103723,1103769
teRNA_18.14 C1orf159 Chimeric Non-coding Non-coding chr1(-):1082967,1082987,1083915,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1090876,1090983,1091472,1091565,1091991,1092103,1095077,1095124,1103723,1103769
teRNA_18.15 C1orf159 Chimeric Non-coding Non-coding chr1(-):1082967,1082987,1084353,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1095077,1095124,1103723,1103769
teRNA_18.16 C1orf159 Chimeric Other MALRHLALLAGLLVGVASKSMENTAQLPECCVDVVGVNASCPGASLCGPGCYRRWNADGSASCVRCGNGTLPAYNGSECRSFAGPGAPFPMNRSSGTPGRPHPGAPRVAASLFLGTFFISSGLILSVAGFFYLKRSSKLPRACYRRNKAPALQPGEAAAMIPPPQSSDVGSAGKEDPPRQGRPPIPAPP* chr1(-):1082967,1082987,1083915,1084086,1084353,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1095077,1095124,1103723,1103769
teRNA_18.17 C1orf159 Chimeric Non-coding Non-coding chr1(-):1082967,1082987,1083915,1084086,1084353,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1091278,1091374,1091472,1091565,1091991,1092103,1095077,1095124,1103723,1103769
teRNA_18.18 C1orf159 Chimeric Non-coding Non-coding chr1(-):1082967,1082987,1083915,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1091374,1091472,1091565,1091991,1092103,1095077,1095124,1103723,1103769
teRNA_18.19 C1orf159 Chimeric Non-coding Non-coding chr1(-):1082967,1082987,1083915,1084011,1084353,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1095077,1095124,1103723,1103769
teRNA_18.20 C1orf159 Chimeric Non-coding Non-coding chr1(-):1084066,1084086,1084353,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1095077,1095124,1103723,1103769


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).